CM pats Dr Kalapala on his appointment as Associate Editor of IGIE
VIJAYAWADA: Chief Minister N Chandrababu Naidu has congratulated Dr Rakesh Kalapala, who is the Director of Endoscopy at the AIG Hospitals in Hyderabad on his appointment as the Associate Editor of the iGIE, the official journal of the American Society for Gastrointestinal Endoscopy (ASGE).
In his message through 'X', the Chief Minister said, 'Heartiest congratulations to Dr Rakesh Kalapala, the Director of Endoscopy at AIG Hospitals' Centre for Obesity and Metabolic Therapy on his prestigious appointment as Associate Editor of iGIE, the official journal of American Society for Gastrointestinal Endoscopy (ASGE). This recognition honours Dr Kalapala's expertise and shines as a global spotlight on India's growing leadership in advanced medical research,' Naidu said. The Chief Minister also said that Dr Kalapala's achievement brings tremendous pride to both the Telugu community and the nation as well. Naidu wished Dr Kalapala continued success as he represents Indian medical excellence on the international platform.
The AIG Hospitals too through 'X' congratulated Dr Kalapala on his appointment as the Associate Editor of iGIE and wished him a continued success as he contributes to shaping the future of endoscopic science and clinical practice across the globe. This prestigious editorial role reflects Dr Kalapala's global recognition as a leader in advanced endoscopy and obesity management, the AIG Hospitals said in its message.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
21 minutes ago
- Time of India
Singapore SCID case: Indian-origin baby beats rare disorder; Stem-cell transplant saves life
Representative photo A 19-month-old Indian-origin boy in Singapore has made a remarkable recovery from a rare and life-threatening genetic disorder, thanks to a timely stem-cell transplant , according to a report by The Straits Times. Mannat Singh was just six days old when doctors diagnosed him with severe combined immunodeficiency (SCID), a condition that left him dangerously vulnerable—even to something as common as the flu. Born in Singapore, Mannat holds the distinction of being the first baby in the country to be diagnosed with SCID at birth. He underwent a successful stem-cell transplant in 2023, a crucial step that came before the onset of symptoms. Today, Mannat is thriving, the newspaper reported. His specific condition, known as Artemis SCID , is an extremely rare and recessive form of radiosensitive SCID. This meant certain treatments like radiation and specific scans were off-limits. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất IC Markets Đăng ký Undo Without intervention, Mannat would not have survived beyond his first birthday, the report said. His mother, Harminder Kaur, a 39-year-old nurse, spoke about the emotional weight she carried after learning about her son's condition. 'Because I made him this way,' she said, recalling her initial feelings of guilt and fear. His father, Harminder Singh, also 39 and an IT consultant, admitted the prognosis was hard to accept. 'It did not help our state of mind when his odds were stacked against him,' he said. Now, with Mannat healthy and growing, Kaur said, 'I feel now that life has returned to normal and we have put the past behind us.' The diagnosis was made at KK Women's and Children's Hospital (KKH) through the National Expanded Newborn Screening (NENS) programme. Launched in 2006, NENS initially aimed to screen all newborns in Singapore for metabolic and heritable diseases. In 2019, the programme broadened its scope to include five additional treatable childhood-onset conditions , including SCID and cystic fibrosis. Dr Bianca Chan, a consultant in the rheumatology and immunology service at KKH, emphasized the importance of early detection. 'The highest success is when it is performed within the first three to four months of life, before the baby develops significant infections. This makes SCID screening at birth crucial for early diagnosis to actively prevent infection,' Dr Chan said. She added that the only real cure for SCID is a bone marrow transplant from a healthy donor. Stem cells from the donor's bone marrow can develop into the T-cells that SCID babies critically lack, allowing them to build a functioning immune system. (With PTI inputs)
India Today
an hour ago
- India Today
Appendix cancer on the rise among US millennials, new study finds
From breast and colon to stomach and pancreatic cancers, doctors are now seeing more cases in people under the age of 50. A new study adds another surprising cancer to that list: appendix it remains extremely rare, appendix cancer is steadily increasing, especially among younger generations - millennials and Gen Z in the US, according to new research published in the Annals of Internal study, led by researchers at Vanderbilt University Medical Centre, found that the number of people diagnosed with a type of appendix cancer called appendiceal adenocarcinoma (AA) has spiked in recent decades. Using data from the National Cancer Institute's SEER program, a comprehensive US cancer registry, researchers tracked cases between 1975 and analysed trends by birth cohort and discovered a clear pattern: people born after 1945 showed rising rates of appendix cancer, with the sharpest increases among those born in 1980 and 1985. A study found that the number of people diagnosed with a type of appendix cancer has spiked in recent decades. () advertisementIn fact, rates tripled for the 1980 birth cohort and quadrupled for the 1985 group when compared to people born in 1945."This suggests that something has changed in the environment or lifestyle of newer generations that's contributing to this rise,' said lead researcher Dr. Andreana Holowatyji, assistant professor of hematology and oncology at IS THIS HAPPENING?Unlike more common cancers, the causes of appendix cancer remain appendix, a small pouch attached to the large intestine, was long overlooked and often lumped in with colon cancer. But as diagnostic tools and cancer registries improve, it's become easier to track this specific type of the number of appendectomies (surgical removal of the appendix) has stayed the same over the years, the researchers rules out the possibility that more cancers are simply being discovered because more surgeries are being researchers believe that lifestyle and environmental factors may be to blame. Rising rates of obesity and metabolic disorders among younger generations are a known risk factor for several cancers. But Holowatyji says it's probably not just one thing. The appendix, a small pouch attached to the large intestine, was long overlooked and often lumped in with colon cancer. () "It's likely a combination of influences, things like diet, chemicals in the environment, or even changes in the gut microbiome, that could be triggering changes in the body's cells and increasing the risk," she told IT MATTERS FOR INDIA'S YOUNG ADULTSThough the study was based on US data, the findings carry relevance globally, including for Indian millennials and Gen is also seeing an increase in young people diagnosed with cancers traditionally considered diseases of older inactive for long periods, high intake of processed diets, exposure to pollution, and lack of early screening all play a appendix cancer is still so rare, awareness among doctors and the public is low. This means symptoms, like unexplained bloating, changes in bowel habits, or appetite loss, can easily be dismissed as minor digestive authors of the study are calling for more research into the causes of appendix cancer, especially in younger populations, increased awareness not just among medical professionals but also among young adults themselves. advertisement
Hindustan Times
2 hours ago
- Hindustan Times
Chandigarh: Need to draw lessons from Covid-19 to prepare for future pandemics, says Dr VK Paul
While addressing 63 professionals gathered to attend fourth Postgraduate International Vaccinology Course, Dr Vinod Kumar Paul, member of NITI Aayog, focussed on drawing lessons from the Covid-19 pandemic and preparing for future pandemics. The course is being organised by the department of community medicine and school of public health of PGIMER. In the inaugural ceremony, connecting through video call, Dr Paul highlighted the Indian journey of building Covid-19 vaccine and how India navigated through the pandemic in his keynote address. He said, 'During Covid-19, the vaccine was developed in about 9 months globally and we were in step the global time, but next time around it has to be developed within 100 days of the pandemic being declared. For that we have to work hard today. You need to keep your clinical trials ready, study immune response, biology of potential pathogens, keep the labs ready and create capacity within the industry.' He added, 'During Covid-19 pandemic, nobody came to our rescue, there were hardly any vaccines to be offered to India. We survived because we produced our home vaccines, we survived because we had the capabilities.' Dr Paul emphasised on delivering the vaccine within 100 days whenever the pandemic like situation occurs in future. Dr Rajeev Raghuvanshi, drug controller general of India, delivered the address emphasising the importance of innovation, regulation, and India's leadership in vaccine research. The five-day academic event aims to be a transformative learning experience, equipping participants with advanced knowledge and practical insights in the field of vaccinology.
